Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2003-06-05
2008-09-23
Blanchard, David J. (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C424S130100, C530S388230, C536S023530
Reexamination Certificate
active
07427471
ABSTRACT:
The invention relates to the field of antibodies, and particularly to modified antibodies, methods of preparing modified antibodies and uses thereof. More particularly, the invention relates to the preparation of more active IgG antibodies by the addition of an extra immunoglobulin domain to the constant region.
REFERENCES:
patent: 644792 (1900-03-01), Gray et al.
patent: 5834597 (1998-11-01), Tso et al.
patent: 5959177 (1999-09-01), Hein et al.
patent: 6045795 (2000-04-01), Ulevitch et al.
patent: 6284536 (2001-09-01), Morrison et al.
patent: WO 00/09560 (2000-02-01), None
patent: WO 00/09560 (2000-02-01), None
Cavacini et al. (J. Immunol. 155:3638-3644 (1995)).
Burgess et al, (Journal of Cell Biology vol. 111 Nov. 1990 2129-2138).
Lazar et al (Molecular and Cellular Biology Mar. 1988 vol. 8 No. 3 1247-1252).
Schwartz et al, (Proc Natl Acad Sci USA vol. 84:6408-6411 (1987).
Lin et al Biochemistry USA vol. 14:1559-1563 (1975).
Ibragimova and Wade (Biophysical Journal, Oct. 1999, vol. 77, pp. 2191-2198).
Dangl et al. (EMBO J. 7(7):1989-1994 (1988).
Batra et al. (Molecul. Immunol. 30(4):379-386 (1993).
Schneider et al. (PNAS, USA. 85:2509-2513 (1988).
Doring et al. (Molecul. Immunol. 31:1059-1067 (1994).
Stratagene Catalogue (1988).
Dangl, J.T. et al. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. The EMBO Journal. vol. 7, No. 7, pp. 1989-1994.
Cavacini, L.A. et al. Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody. The Journal of Immunology, 1995, vol. 155, pp. 3638-3644.
Roux, H.K. et al. Comparisons of the ability of human IgG3 hinge mutants, 1gM, IgE, and IgA2, to form small immune complexes; Arole for flexibility and geometry. The Journal of Immunology, 1998, vol. 161, pp. 4083-4090.
Greenwood et al, “Structural motifs involved in human IgG antibody effector functions,m” Eur. J. Immunol. 1993, 23:1098-1104.
Greenwood, et al., “Engineering Multiple-Domain Forms of the Therapeutic Antibody CAMPATH-1H: Effects on Complement Lysis,” Therapeutic Immunology, 1: 247-255 (1994).
Ma, et al., “Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants,” European Journal of Immunology, 24: 131-138 (1994).
Isogai, et al., “Therapeutic effect of anti-TNF-α antibody and levofloxacin (LVFX) in a mouse model of enterohemorrhagicEscherichia coliO157 infection,” Comparative Immunology, Microbiology & Infectious Diseases, 24: 217-231 (2001).
Scallon, et al., “Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency,” Molecular Immunology, 41: 73-80 (2004).
Kadokami, et al., “Anti-Tumor Necrosis Factor-α Antibody Limits Heart Failure in a Transgenic Model,” Circulation, 104: 1094-1097 (2001).
Supplementary European Search Report dated Mar. 12, 2007.
Cai Ann
Naso Michael
Scallon Bernard J.
Blanchard David J.
Bristol Lynn
Centocor, Inc.
Dow Kenneth J.
LandOfFree
Modified “S” antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified “S” antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified “S” antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3984023